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1562Objective: Increasing evidence shows that some cardiac defects may benefit from fetal interventions, including
fetal cardiac surgery. We attempted to develop an in vivo animal model of fetal cardiopulmonary bypass with
cardioplegic arrest.
Methods: Operations were performed on 14 pregnant goats. The extracorporeal circulation circuit consisted of
a centrifugal pump, silicone tubings with an inner diameter of 6 mm, a roller pump, and a reservoir. The placenta
was the sole oxygenator. Cardiopulmonary bypass was maintained at a mean flow rate of 344  68 mL/kg/min,
including 30 minutes of cardiac arrest and 15 minutes of reperfusion. Mean arterial blood pressure and heart
rate were monitored. Arterial blood samples were analyzed. The pulse index and resistance index of the fetal
umbilical artery were monitored.
Results: Experiments were completed in 11 cases (79%), with the fetuses weighing 0.65 to 1.8 kg. Fetal mean
arterial blood pressure and heart rate remained stable throughout the experiments. A decrease in partial pressure
of oxygen with concomitant increase in carbon dioxide partial pressure was noted, but trends were relatively
stable. Metabolic acidosis was recognized during and after cardiac bypass. The pulse index and resistance index
of the umbilical artery increased significantly after 2 hours off bypass.
Conclusions:We confirmed the technical feasibility of establishing an in vivomodel of fetal cardiac bypass with
cardioplegic arrest. This fetal goat model provides reproducible data and is suitable to study clinically relevant
problems related to fetal cardiopulmonary bypass, myocardial protection, and hemodynamics. (J Thorac Cardi-
ovasc Surg 2011;142:1562-6)Some severe fetal cardiac disease is progressive and in-
volves secondary damage to the rapidly growing pulmonary
bed and ventricles,1-3 affecting postnatal treatment options
and prognosis, and may require palliative rather than
definitive surgical procedures. Some fetuses with cardiac
abnormalities may also develop cardiac failure and
fetal hydrops, leading to a higher rate of intrauterine fetal
demise or early neonatal death. Theoretically, in utero
therapy might improve the outcome. There is increasing
evidence that some of these defects may benefit from fetal
interventions, including fetal cardiac surgery.4-6 If the
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ventricle physiology can be avoided.
There is no safe and effective method to gain access to
perform open surgery in the fetus. A motionless and blood-
less field is absolutely necessary to permit the meticulous
intracardiac repair. Furthermore, little is known about the
pathophysiologic effect of cardiopulmonary bypass (CPB)
with cardioplegic arrest on the developing fetus.
The feasibility of safely supporting the fetus during by-
pass has been demonstrated, when placental dysfunction
was prevented by overcoming the detrimental response of
the placenta to bypass.7-9 Studies on fetal myocardial
protection have been carried out, but research is limited
and principally relies on isolated heart models.10,11 The
requisite techniques to safely arrest and protect the fetal
myocardium during cardiac interventions need to be
developed.
By using existing beating-heart models of CPB in fetal
goats, we developed a clinically relevant model of perform-
ing open surgery that allows administration of antegrade
cardioplegia and crossclamping in the fetus. We also
assessed the hemodynamics of fetal-placental circulation
after fetal cardiac bypass. This novel model enables us to
study the various pathophysiologic effects of CPB with car-
dioplegic arrest on hemodynamics and myocardial protec-
tion in vivo. Defining these mechanisms has significantgery c December 2011
FIGURE 1. Extracorporeal circuit consisted of centrifugal pump (A), flow
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
EDV ¼ end-diastolic velocity
HR ¼ heart rate
MAP ¼ mean arterial pressure
PI ¼ pulse index
RI ¼ resistance index
SPV ¼ systolic peak velocity
TAMAX ¼ time-averaged maximum velocity
Liu et al Evolving Technology/Basic Scienceimplications for the successful translation of fetal cardiac
surgery in vivo.probe (B), arterial cannula (C), venous cannula (D), and silicone tubing
with an inner diameter of 6 mm for the arterial and venous lines. Another
silicone tubing coupled to a roller pump and reservoir with filter was
inserted via a Y connector (E) into the venous line of the extracorporeal
-circuit for left heart venting (not shown).
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Animals
The study protocol was approved by the Animal Research Committee of
Guangdong Provincial People’s Hospital. All animals were handled in ac-
cordance with the Guidelines of Guangdong Provincial People’s Hospital
for Laboratory Animal Studies. Operations were performed on singleton
and twin fetuses carried by mixed-breed, time-dated pregnant goats
(110–130 days, term ¼ 150 days).
Anesthesia and Monitoring
Pregnant goats (n¼ 14) were anesthetized by intramuscular injection of
10 to 20 mg/kg ketamine (Gutian Pharmacy Co, Fujian, China) and then
intubated endotracheally. Arterial oxygen saturation was maintained at
100%, and arterial carbon dioxide tension was maintained at approxi-
mately 30 mm Hg. Catheters were placed in the goats’ femoral artery
and jugular vein for measurement of blood gases and delivery of intrave-
nous fluids, respectively. Maternal arterial pressure and heart rate (HR)
were monitored. Anesthesia was maintained with 5 mg/kg intravenous fen-
tanyl per hour (Renfu Pharmacy Co, Yichang, China) and 0.1 mg/kg intra-
venous vecuronium per hour (Xianjun Pharmacy Co, Zhejiang, China).
Operation
The uterus was exposed through a midline laparotomy. The number and
orientation of the fetus were determined, and 50 mg fentanyl and 0.2 mg
vecuronium were administered intramuscularly to the selected fetus.
A hysterotomy was performed to expose a forelimb in which the axillary
artery was cannulated to monitor fetal arterial blood pressure and HR.
Anesthesia was maintained with ketamine 5 mg/h via the axillary vein.
Fetal Cardiac Pulmonary Bypass
The extracorporeal circulation circuit consisted of a nonpulsatile cen-
trifugal pump (BP50; Medtronic, Inc, Minneapolis, Minn), silicone tubing
with an inner diameter of 6 mm for the arterial and venous line (length 90
cm), another silicone tubing coupled to a roller pump (Stockert Instrumente
GmbH, Munich, Germany), and cardiotomy reservoir with filter via a Y
connector into the venous line of the extracorporeal circuit to confirm the
left heart venting (Figure 1). The placenta was the sole oxygenator. Ap-
proximately 50 mL of the heparinized maternal blood containing 10 mg
heparin, 50 mg methylprednisolone, and 5 mL 5% sodium bicarbonate
was used to prime the pump circuit.
A midline fetal sternotomy was performed, and the pericardium was
opened. Heparin (10 mg; Shanghai No 1 Biochemistry Pharmacy Co,
Shanghai, China) was administered intravenously before cannulation. A fe-
tal cardiac bypass was instituted after cannulation of the main pulmonaryThe Journal of Thoracic and Carartery using an 8F DLP arterial cannula (Medtronic, Inc) and the right
atrium using a 16F straight venous cannula (Medtronic, Inc). After ensur-
ing the absence of any air bubbles within the circuitry, CPB was initiated.
Because of the need for high flows when the placenta is incorporated into
the circulation for oxygenation, pump flows were maintained at the maxi-
mum achievable flow in each animal (the mean value for a stable pump flow
is 344 68 mL/kg/min). Fetal body warming was ensured with an infrared
lamp and gauze soaked in warm saline. Fetal body temperature was satis-
factorily maintained during and after bypass, and the maximum gradient
between pre-bypass and bypass temperatures did not exceed 3C.
Fetal Cardiac Arrest
Immediately on reaching stable target bypass flow rates (2–3 minutes),
the aorta was crossclamped and cardioplegic arrest was induced by cold
modified St Thomas cardioplegia (4C) without calcium solution to a total
of 25 mL/kg estimated fetal body weight. Topical cooling using ice slush
was used. A left heart venting catheter through the left auricle coupled to
a reservoir and roller head pump was used for decompression of the fetal
heart. After 30 minutes of myocardial ischemia, the aortic crossclamp
was released and the heart was reperfused. After clamp removal, the fetal
heart spontaneously resumed normal sinus rhythm. Bypass continued for
15 minutes before the animals were weaned from CPB. Heparin was not
antagonized routinely. After cessation of CPB, the animals were decannu-
lated. The fetuses were then monitored for 2 hours. After the completion of
study, the fetuses were killed for autopsy and measurement of fetal weight.
Ultrasonographic Measurements
For ultrasonographic examinations, the ultrasound system GE LOGIQ
book XP (GE,Wuxi, China) equipped with a (4–10MHz) linear transducer
probe for B-mode and color-coded and pulsed Doppler measurements was
used. The umbilical artery was first visualized by means of color-coded
Doppler. Then a pulsed Doppler flow velocity waveforms sample volume
was placed exactly in the center of the color-coded blood flow, and the
waveforms of at least 3 consecutive cardiac cycles were recorded; thus,
the measurements of 3 different waveforms for each vessel were taken.
The systolic peak velocity (SPV), end-diastolic velocity (EDV), time-
averaged maximum velocity (TAMAX), pulse index (PI), and resistance
index (RI) were automatically calculated for each waveform (PI ¼ SPV
– EDV/TAMAX, RI ¼ SPV – EDV/SPV).diovascular Surgery c Volume 142, Number 6 1563
TABLE 1. Fetal hemodynamic data and results of blood gas analysis (c2 ± standard deviation)
Before bypass On bypass Cardiac arrest 1 h off bypass 2 h off bypass
HR (beat/min) 177  25 129  24 0  0 149  29 139  25*
MAP (mm Hg) 64.9  7.8 63.6  16.9 51.2  14.9 60.6  7.8 59.6  10.7
PACO2 mm Hg 37.9  9.5 43.5  15.9 41.6  12.1 46.2  12.3 49.0  14.7*
PaO2 mm Hg 29.6  5.5 23.4  13.6 29.9  11.5 24.3  8.8 23.3  7.7*
Base excess (mmol/L) 5.4  4.3 4.7  3.9 3.8  3.6 14.5  3.8* 15.5  4.4*
Lactic acid (mmol/L) 3.1  1.6 6.2  2.5* 5.8  1.4* 10.6  2.4* 10.9  2.7*
pH 7.33  0.11 7.30  0.13 7.32  0.15 7.11  0.12* 7.08  0.17*
Hematocrit (%) 33  7 24  6* 20  6* 25  6* 23  7*
*P<.05 vs before bypass values.
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Maternal and fetal HRs and arterial blood pressure were monitored
continuously during the experiments. Maternal and fetal arterial blood
was collected for blood gas and metabolite analysis immediately on gain-
ing arterial access, on cardiac bypass before arrest, after 15 minutes of
arrest, and 60 and 120 minutes after weaning from CPB. The PI and RI
of the fetal umbilical artery were monitored after heparin administration
and 60 and 120 minutes after weaning from CPB.
Statistical Analysis
Data are presented as the mean  standard deviation. Data were sub-
jected to repeated-measure analysis of variance. Statistical analysis was
performed with the SPSS 13.0 software package (SPSS Inc, Chicago, Ill).TABLE 2. Pulse and resistance indexes of umbilical artery (c2 ±
standard deviation)
Before bypass 1 h off bypass 2 h off bypass
PI 0.69  0.16 0.64  0.13 0.89  0.06*
RI 0.49  0.10 0.48  0.09 0.58  0.04*
*P<.05 vs. 1 h off bypass values.RESULTS
Experiments were completed in 11 cases (79%), with the
fetuses weighing from 0.65 to 1.8 kg (1.2 0.36 kg). Pump
flow varied from 290 to 480 mL/min with a mean flow rate
of 344 68mL/kg/min at steady state. All experimental an-
imals were hemodynamically stable throughout the study
period. Fetal body temperature decreased to 36C during
bypass but slowly warmed to baseline (39C) after weaning
from CPB. Only 1 fetus did not survive to cardioplegic ar-
rest. The cause of fetal demise was tearing of the fragile
right atrial tissue during aortic crossclamping. One fetus
could not be weaned from CPB because of insufficient car-
diac activity most likely due to air embolism to the coronary
arteries. One fetus was weaned from bypass for approxi-
mately 1 hour but developed low cardiac output with severe
low blood pressure. We reinstituted extracorporeal circula-
tion, but the fetus could not beweaned from CPB again. The
cause of cardiac failurewas attributed to air embolism to the
coronary arteries.
Fetal mean arterial pressure (MAP) remained stable
throughout the experiments at each time point, and there
was no difference between corresponding time intervals.
Fetal HR was well maintained. However, HR was signifi-
cantly decreased at 120 minutes after weaning from cardiac
bypass compared with the baseline value (HR, 177  25 to
139  25 beats/min; Table 1).
Fetal blood gas analysis is shown in Table 1. A stable de-
crease in partial pressure of oxygen (PO2) with a concomi-
tant stable increase of carbon dioxide partial pressure1564 The Journal of Thoracic and Cardiovascular Sur(PCO2) was noted. At 120 minutes after weaning from car-
diac bypass, the PACO2 (37.9  9.5 to 49.0  14.7 mm
Hg) and PaO2 (29.6  5.5 to 23.3  7.7 mm Hg) were sig-
nificantly different from that of the baseline (P< .05 for
both), suggesting impairment of the placental function.
Metabolic acidosis was also noted during and after cardiac
bypass, manifested by the alterations in lactic acid, pH, and
base excess. These deteriorative responses progressed after
cessation of cardiac bypass; however, no significant differ-
ence was seen 1 to 2 hours after cardiac bypass. The hemat-
ocrit decreased significantly on initiation of CPB (pre-CPB
33  7; on CPB 24  6) because of fetal hemodilution and
surgical blood loss, but remained stable for the remaining
period of the experiment.
The PI and RI of the umbilical artery remained the same
as at baseline 1 hour after off CPB but were significantly
elevated 2 hours after off bypass, suggesting there was an
increase in placental vascular resistance and that placental
dysfunction was a time-dependent process (Table 2).
DISCUSSION
The present study describes a fetal goat model of CPB in-
cluding cardioplegic arrest and ischemia, weaning from
CPB, and assessment of hemodynamic. The model provides
reproducible stabile hemodynamics 120 minutes after CPB
and offers a reproducible and reliable method to study in-
vivo effects regarding hemodynamic and myocardial per-
formance after fetal cardiac arrest. A number of fetal goat
CPB models have demonstrated that it is technically possi-
ble to place the fetal goat on CPB and separate from CPB.
Furthermore, Fenton and colleagues7 and Reddy and col-
leagues12 reported their experiences with fetal goat bypass
models that subsequently delivered normal full-term
fetuses. Of note, all the different experimental settings
have been performed on beating-heart CPB. To date, nogery c December 2011
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cardioplegic arrest has been developed, and little is known
about the pathophysiologic effect of CPB including cardiac
arrest on the developing fetus. Malhotra and associates10,11
used an isolated fetal heart preparation in an attempt to
examine fetal myocardial protection. To our knowledge,
the only model of in vivo fetal CPB with cardioplegic
arrest to evaluate the various ways of myocardial
protection was reported by Petrucci and associates,13 but
their experimental animal could not be separated from
CPB. An animal model of CPB including cardiac arrest
and ischemia, weaning from CPB, on an experimental basis
is essential for future investigation of fetal intracardiac
intervention.
Of the 14 experiments we conducted, 11 animals sur-
vived at least 120 minutes post-CPB. In the 3 fetuses that
did not survive to weaning from bypass, the main cause of
failure was tearing of the fragile right atrial tissue and insuf-
ficient cardiac activity most likely secondary to coronary air
embolism. Our circuit design is a closed system that has no
mechanism for preventing air embolism from the venous
cannulation site if the venous line pressure becomes subat-
mospheric in case of tearing of the right atrium. By incorpo-
rating a pericardial pledget into the atrial purse-string as
described,14,15 this technical fault is preventable in future
experiments.
To obtain higher fetal bypass flow rates, after trials with
straight or angled venous cannulae ranging from 12F to 16F,
we found that the 16F straight venous cannula is the best fit
for a fetus of this size, with the greatest ease of insertion and
adequate drainage. Despite the suitable venous cannulae
and verification of right atrial emptying during bypass,
poor decompression of the fetal heart was observed. We
noted the patent foramen ovale was unusually positioned
distally toward the inferior vena cava. The patent foramen
ovale opens like a valve, allows most of the blood entering
the right atrium from the inferior vena cava to pass into the
left atrium, and prevents passage of blood in the opposite di-
rection because the septum primum closes against the rela-
tively rigid septum secundum. A left heart vent catheter
through the left auricle coupled to a reservoir and roller
head pumps solved this particular problem and provided
stability during bypass. In addition, this approach had the
added advantage of saving blood by allowing its recircula-
tion from the surgical field through the roller pump.
Our group elected to use the autoplacenta for fetal gas ex-
change to simplify the circuit and avoid activation of a stress
response associated with exposure to foreign surfaces (arti-
ficial membrane lung, CPB tubing).16,17 The results of blood
gas analysis showed that PO2 and PACO2 were all adversely
affected, but within an acceptable range, and represented
good gas exchange effects of the autoplacenta. Our results
suggested the modulating effect of the autoplacenta on
fetal gas exchange mechanism, at least for a short arrestThe Journal of Thoracic and Carperiod of 30 minutes and a total CPB time not more than
1 hour.
The present study also showed that cold modified St
Thomas cardioplegia excluding any calcium solution,
which is most commonly used in neonatal surgery in
Guangdong Provincial Cardiovascular Institute, provided
quick arrest of the fetal heart. Previous work has demon-
strated that hypocalcemic cardioplegia solutions offer better
protection in neonates18 and in vitro studies examining the
effect of cardioplegia calcium content on fetal hearts.10 In
our study, immediate return to regular sinus rhythm and res-
toration of preoperative hemodynamics presented further
indirect evidence that the cardioplegic regimen we used
provided optimal preservation of fetal myocardial function.
Despite our successful fetal support during bypass and
the ease of weaning from the pump and the fetal goats sur-
vived (fetal HR and MAP remained stable during and after
CPB), fetal gas exchange deteriorated (Table 1). In particu-
lar, mixed metabolic and respiratory acidosis developed af-
ter weaning from bypass. Blood gas values were used as an
index of placental function because conditions of the
mother remained stable throughout the procedure. We as-
cribe fetal acidosis to placental dysfunction from hysterot-
omy, technical limitations, stress associated with CPB19-21
and cardiac arrest, or perhaps the exposure of such fragile
fetuses. This study also showed that the immature fetus is
susceptible to increase in placental vascular resistance
(Table 2) and less capable of compensating for metabolic
demands.22,23 Furthermore, inadequate flows (344  68
mL/kg/min) during CPB and cardiac arrest also may have
played a role in poor gas exchange because previous
investigators have reported better placental gas exchange
with higher flows (400–600 mL/kg/min).24 In our experi-
ments, there was no significant difference in the hemody-
namic and metabolic status between 1 and 2 hours after
cardiac bypass, suggesting that the deleterious effects of fe-
tal CPB may not be progressive after the first hour off
bypass.
CONCLUSIONS
This study confirmed the technical feasibility of estab-
lishing an in vivo model of fetal cardiac bypass with cardi-
oplegic arrest and successful weaning from CPB. The data
show that this fetal goat model provides reproducible data
and is suitable to study clinically relevant problems related
to fetal CPB with cardioplegic arrest, myocardial protec-
tion, and hemodynamics. Placental dysfunction was gener-
ally not prevented in this study. Further experimental
evaluation including bypass circuit design, pharmacologic
or other means to alleviate the adverse effects of CPB-
induced inflammatory response on placental function, and
comprehensive fetal perioperative monitoring will be nec-
essary to move forward to the clinical application of this
challenging surgical intervention.diovascular Surgery c Volume 142, Number 6 1565
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